TheStreet.com  Dec 30  Comment 
DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons. Must Read: Warren Buffett's Top 10 Dividend Stocks They might need the cash for a big personal purchase such as a new house or yacht, or...
Benzinga  Dec 23  Comment 
Among Tuesday's biggest gainers, there are a few with elevated short interest. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) The biopharmaceutical company focused on developing products for the treatment of the central nervous system sports a...
Benzinga  Dec 23  Comment 
NQ Mobile Inc (ADR) (NYSE: NQ) +27% - The company announced an $80 million repurchase program. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) +15% - Novartis AG announced it will make a $25 million investment in Vanda. China Finance Online Co....
Benzinga  Dec 23  Comment 
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) surged 19.06% to $14.18. The volume of Vanda Pharmaceuticals shares traded 952% higher than normal. Vanda Pharmaceuticals announced its plans to acquire rights to Phase II clinical compound from Novartis...
Benzinga  Dec 23  Comment 
Benzinga  Dec 23  Comment 
NQ Mobile Inc. (NYSE: NQ) shares jumped 15.61% to $4.00 in pre-market trading. NQ Mobile's board authorized an up to$80 million shares buyback plan. China Finance Online Co., Ltd. (NASDAQ: JRJC) shares gained 21.24% to $6.45 in the pre-market...
Benzinga  Dec 23  Comment 
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) announced on Monday that it has agreed to settle a dispute over the rights to Fanapt with Novartis AG (ADR) (NYSE: NVS). Under the agreement, Novartis will transfer all rights relating to Fanapt to Vanda...
The Australian  Dec 19  Comment 
CVC Limited chairman Vanda Gould resigned yesterday after a judge referred a $30m tax case to the Commonwealth DPP.
StreetInsider.com  Oct 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vanda+Pharmaceuticals+%28VNDA%29+Prices+5M+Offering+at+%2411.60Share/9952561.html for the full story.
Benzinga  Oct 27  Comment 
Chembio Diagnostics (NASDAQ: CEMI) gained 21.56% to $4.85 after the company reported that it has partnered with Integrated BioTherapeutics to develop point-of-care diagnostic tests for Ebola and Febrile Illness. Alexza Pharmaceuticals (NASDAQ:...

You may also be interested in articles related to Vanda Pharmaceuticals (VNDA):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki